Household Transmission | CDC/FDA Updates | January 25, 2021
Date of Presentation: January 25, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #covid clinical updates #covid resource drop #household transmission
In this series of presentations, Dr. Thomas Becker, Medical Epidemiologist and ECHO faculty member, provides a summary and article review of COVID-19 transmission. Then, Eileen M. Dunne, PhD, Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention at the Idaho Division of Public Health and ECHO faculty member, provides a number of valuable COVID-19 related resources produced by the CDC and FDA.
Recording:
Presented by:
Dr. Tom Becker, Dr. Eileen M. Dunne
Thomas Becker, MD, PhD, is a medical epidemiologist, and trained in internal medicine, anthropology, and public health; he began his career at the University of New Mexico before moving to the Northwest about 20 years ago. Since his arrival in Portland, Becker has worked with the Northwest Portland Area Indian Health Board and Oregon Health & Science University. He has published on a diverse range of American Indian health issues, including both infectious and chronic diseases. And with the Indian Health Board, he has been involved in etiologic studies, community prevention programs and education programs to improve career opportunities for people in tribes nationwide.
Eileen M. Dunne, PhD, is an Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention at the Idaho Division of Public Health, Bureau of Communicable Disease Prevention
Resources Provided:
- COVID-19 Household Transmission (Presentation Slides)
- Public Health Updates (Presentation Slides)
- Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study (Lancet)
- Novel Coronavirus Disease 2019 (COVID-19): Interim Investigative Guidelines (Oregon Health Authority)
- mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants (pre-print: bioRxiv)
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera (pre-print: bioRxiv)
- Web-Based Locator for COVID-19 Outpatient Treatment Sites for Monoclonal Antibodies (HHS)
- Therapeutics Distribution Locations
- HHS, DOD purchase additional doses of Regeneron’s antibody therapeutic to treat patients with mild to moderate COVID-19 (HHS)
- Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff (FDA)
- CDC Expands Negative COVID-19 Test Requirement to All Air Passengers Entering the United States (CDC)
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020 (MMWR)
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021 (MMWR)
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021 (MMWR)
- National Strategy for the COVID-19 Response and Pandemic Preparedness (White House)
- V-safe After Vaccination Health Checker (CDC)
Date added: January 25, 2021